Mayotte vs Philippines: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Mayotte
0.8%
in 2024
Philippines
0.8%
in 2024
Mayotte rank
37th
Philippines rank
37th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Mayotte
- Philippines
How they compare
Mayotte currently reports 0.8% against 0.8% in Philippines, a difference of 0.0%.
The two have swapped places 3 times across 10 shared years of data; in 2015 it was Mayotte ahead.
Mayotte ranks 37th and Philippines ranks 37th of 215 countries.
Across the 2 decades both report, Mayotte averaged higher in 1 and Philippines in 1.
Head to head by decade
| Decade | Mayotte | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.2% | 0.9% | 0.3% | Mayotte |
| 2020s | 0.8% | 0.9% | 0.0% | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Mayotte or Philippines?
- Mayotte, at 0.8% against 0.8% in Philippines as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Mayotte and Philippines?
- 0.0%, with Mayotte ahead.
- How many years of comparable data are there for Mayotte and Philippines?
- 10 years are reported by both, from 2015 to 2024.
- How do Mayotte and Philippines rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Mayotte ranks 37th and Philippines ranks 37th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.